CARLYANNE WENZEL: Open Payments
NPI 1477150746 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 13 payments from 9 companies in 2025. Trend: 2023 $406 · 2024 $463 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| ICU Medical Inc | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Abbott Laboratories | 1 | $25 |
| Amgen Inc. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: WAINUA, ByPass, VERQUVO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LOKELMA, REPATHA, LEQVIO, VYNDAQEL.
Industry payments across IN — which companies pay providers there.
